joimax® presents product portfolio at JSSR in Yokohama Japan
Further continues International Growth Strategy

Karlsruhe, GER– April 18, 2019 – joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic, minimally-invasive spinal surgery, is presenting its complete product portfolio at the 48th Annual Meeting of the Japanese Society for Spine Surgery and Related Research (JSSR, http://www.jssr.gr.jp/english/). The annual meeting is currently underway running April 18-20, 2019 in Yokohama, Japan. joimax(R) presence at JSSR Yokohama, Japan, endoscopicspine surgery, Minimally invasive, Transforaminal, Interlaminar, Training and Education, Japan, United Biomech Inc., JSSR

Earlier this year, joimax® announced its partnership with United Biomech Japan, Inc., who is overseeing distribution of the complete joimax® product line throughout Japan. Approval of the Pharmaceutical Medicals and Medical Devices Agency (PMDA) is expected within the next couple of months.

“The Japanese market is characterized by a strong demand for innovative products on endoscopic spinal surgery,” explained United Biomech Japan, Inc. Executive Kazuya Oribe. “The interest at our booth is overwhelming. There are approximately one thousand Japanese surgeons that are now already interested in doing endoscopic spinal surgery.”

“The patients’ demand for gentle surgery methods that result in a very quick recovery, is continuously increasing,” said joimax® Group Founder and CEO Wolfgang Ries. “Our entrance into the Japanese market is another milestone in expanding our global presence to offer superior medical products. Coupled with an outstanding, international training and education program, we’ve positioned ourselves for long-term growth.”